Provider

By Jonah Comstock February 19, 2017
At the Pop Health Forum last fall, Cleveland Clinic Chief Experience Officer Dr. Adrienne Boissy talked about her definition of patient engagement, and how much bigger it is than just apps. At the Personal and Digital Connected Health event at HIMSS today, Boissy expanded on those ideas, giving several specific examples of how Cleveland Clinic is realizing those ideas. “Patients should be...
By MobiHealthNews February 17, 2017
This week in Paris, companies in the diabetes managment space came together at the Advanced Technologies and Treatments for Diabetes conference to share news and, mostly, a lot of efficacy data. It's an exciting time for the space as closed-loop systems that allow people with diabetes to monitor their glucose continuously and automatically manage their insulin dosing get closer and closer to...
By Heather Mack February 17, 2017
In a head-to-head comparison of sensor-augmented insulin pumps, the touchscreen device from Tandem Diabetes Care outperformed that from Medtronic, according to new data presented at the Annual Advanced Technologies and Treatments for Diabetes conference in Paris. The self-reported data from San Diego-based Tandem comes from a retrospective study analyzing de-identified data from 3,046 Tandem SAP...
By Jonah Comstock February 16, 2017
A Swiss medical device company is working on a medically accurate sensor, built into a smartphone, that could return results about heart rate, respiration rate, blood oxygenation, temperature, and -- the use case the company is initially focusing on -- blood pressure. Leman Micro Devices (or LMD or Elemdy) is beginning trials now to simultaneously submit the device for regulatory clearance with...
By Jonah Comstock February 16, 2017
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche. The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
By Heather Mack February 16, 2017
Chronic disease management company Livongo is collaborating with Voluntis, the Paris, France-based company that develops companion apps for medical devices, to offer an integrated program, insulin delivery system and app for people with type 2 diabetes. Members will have access to the Livongo for Diabetes Program with Voluntis’ Insulia, the diabetes management app that received both FDA approval...
By Heather Mack February 16, 2017
The digital physical therapy, telehealth and patient engagement platform from UK-based Physitrack is getting a boost in users thanks to a new partnership with mobile EHR company drchrono. Tapped directly by Apple under the tech giant’s largely stealthy Mobility Partner Program, the two companies are joining forces to integrate Physitrack’s home exercise program into drchrono’s EHR on the web,...
By Heather Mack February 15, 2017
For people going through addiction treatment, relapses can happen at any time. So, operating off the notion that close monitoring could offer more opportunities for early intervention, two health technology companies are working to leverage remote patient monitoring to offer better care to people with alcohol use disorder. Soberlink, makers of a high-tech, FDA-cleared remote breathalyzer, will...
By Jonah Comstock February 15, 2017
When the Church of the Latter Day Saints gifted the 15 hospitals that formed the original Intermountain Health System to the community in 1975, they did it with one mission and one mandate: to create a "model system". Figuring out what that means is the job of everyone at the system, but especially of Todd Dunn, the system's director of innovation. Dunn will talk more about his innovation model...
By Jonah Comstock February 15, 2017
Abbott Diabetes Care shared some real-world evidence this morning at the International Conference on Advanced Technologies & Treatments for Diabetes, bolstering clinical trial data about the effectiveness of the company's Freestyle Libre device line. "We’re certainly committed to sharing as much information as is possible with our users and our health providers in order to be able to make...